A preservative free generic alternative to DuoNeb® (Ipratropium Bromide Bar Coded; Available in the following package configurations per box. Mylan Specialty: DuoNeb is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one. Prescription Drug Information: Duoneb. Ritedose Pharmaceuticals DUONEB- ipratropium bromide and albuterol sulfate solution. Ritedose.

Author: Nikozshura Guzilkree
Country: Rwanda
Language: English (Spanish)
Genre: Software
Published (Last): 17 June 2006
Pages: 130
PDF File Size: 2.86 Mb
ePub File Size: 2.12 Mb
ISBN: 192-9-68412-414-1
Downloads: 41443
Price: Free* [*Free Regsitration Required]
Uploader: Nasho

Geater sensitivity of some older individuals cannot be ruled out.

Mylan Worldwide

Reports of QT prolongation and TdP are noted by duneb manufacturer, primarily in the overdosage setting.

Minor QT prolongation has occurred during therapeutic use of aripiprazole and following overdose.

Metabolic acidosis has been reported with dichlorphenamide and albuterol aerosol and inhalation solution. Although there are no pwckage examining the effects of artemether; lumefantrine in patients receiving other QT prolonging drugs, coadministration of such drugs may result in additive QT prolongation and should be avoided. Drugs with a possible risk for QT prolongation that should be used cautiously and with close monitoring with methadone include the beta-agonists.

Additionally, beta -agonists may cause a decrease in serum potassium in some patients, possibly through intracellular shunting. Send the page ” ” to a friend, relative, colleague or yourself. If coadministration is chosen, and the patient has known risk factors for cardiac disease or arrhythmia, then the patient should be closely monitored. Sudden pxckage and QT interval prolongation have occurred in patients who received nilotinib therapy.

At least one case of hypertension occurred in a patient with previous episodes of high blood pressure who was receiving albuterol and selegiline concurrently.

Serial FEV1 measurements demonstrate that the combination albuterol; ipratropium inhalation Combivent produces greater improvement in pulmonary function than either ipratropium bromide or albuterol sulfate when given separately. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously with fluphenazine include the beta-agonists.


To avoid the spread of infection, do not use the inhaler spray for more than one person. Packaage actuation delivers mcg of albuterol equivalent to mcg of albuterol sulfate and 20 mcg of ipratropium bromide monohydrate. Studies in laboratory animals minipigs, rodents, and dogs have demonstrated the occurrence of cardiac arrythmias and sudden death with histological evidence of myocardial necrosis when beta-agonists and methyl-xanthines are administered concurrently.

Minor Halothane, like other halogenated anesthetics, can prolong the QT interval. One 3-mL vial inhaled via nebulizer 4 times per day. Patients may take additional inhalations as required. More serious effects are rare, but may result in inset cardiovascular effects such as increased blood pressure and heart rate.

Albuterol may exacerbate conditions that are responsive to sympathomimetic stimulation, such as hyperthyroidism thyrotoxicosis, thyroid diseaseconvulsive disorders, diabetes mellitus, seizure disorder or seizures, or hypersensitivity to sympathomimetics pheochromocytoma. Drugs with a possible risk for QT prolongation include the beta-agonists. Although extremely rare, TdP has been reported during post-marketing surveillance of norfloxacin.

DuoNeb Inhalation Solution (Dey), Drug Reference Encyclopedia

Drugs with a possible risk for QT prolongation that should be used cautiously with vemurafenib include the beta-agonists. The pharmacokinetics of Combivent inhalation aerosol was compared to that of Combivent Respimat inhalation spray in a week randomized, double-blind, double-dummy parallel group trial of US patients with COPD. Minor Until further data are available, administer octreotide cautiously in patients receiving drugs that prolong the QT interval, such as the beta-agonists.

Proarrhythmic events should be anticipated after initiation of therapy and after each upward dosage adjustment. Duooneb intravenous administration, approximately one-half is excreted unchanged in the urine. Minor Escitalopram has been associated with QT prolongation. Peak albuterol plasma concentrations occurred at 0. At high doses, loperamide has been associated with serious cardiac toxicities, including syncope, ventricular tachycardia, QT prolongation, TdP and cardiac arrest. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously and with close monitoring with romidepsin include the beta-agonists.


Ipratropium may provide some additive benefit to inhaled betaagonists when treating severe acute asthma exacerbations in the emergency department and, in some instances, during medical transport.

Major When possible, avoid concurrent use of foscarnet with other drugs known to prolong the QT interval, such as short-acting beta-agonists. Other agents associated with a possible risk for QT duonb that should be used cautiously with tacrolimus include the beta-agonists. If vemurafenib and another drug that is associated with a possible risk for QT prolongation and torsade de pointes TdP must be coadministered, ECG monitoring is recommended; closely monitor imsert patient for QT interval prolongation.

Minor Maprotiline has been reported to prolong the QT interval, particularly in overdose or with higher-dose prescription therapy elevated serum concentrations. Although inhaled ipratropium is only minimally absorbed into the systemic circulation, the effects of ipratropium may suoneb additive to other anticholinergic medications.

Therefore, the manufacturer recommends avoiding trazodone in patients receiving other drugs that increase the QT interval. At excessive use or dosages, beta-agonists may produce a transient hypokalemia, which might produce adverse effects in susceptible individuals with cardiac disease, particularly those patients on non-potassium sparing diuretics. The manufacturer recommends avoiding concurrent use of tetrabenazine with other drugs known to prolong QTc, such as beta-agonists.

Most adverse effects observed in human pregnancy are a result of the cardiovascular and metabolic effects of albuterol. The mean terminal half-life of albuterol is roughly 4 hours.